The official blog of the Lung Institute.

Is Silicosis Fatal?

Is Silicosis Fatal?

Yes, silicosis can be fatal. This respiratory disease is caused by inhaling crystalline silica dust, which produces inflammation and scarring when it settles into the lungs. As time passes, this scarring causes the lungs to stiffen. Silicosis is associated with various symptoms that tend to worsen over time, the most common of which include coughing, difficulty breathing and chest pain. It also increases the risk of developing other serious medical conditions, such as tuberculosis, chronic obstructive pulmonary disease (COPD) and lung cancer. Unfortunately, even with treatment, silicosis may ultimately lead to death.

Although there is currently no cure for silicosis, various treatment options exist that can help patients manage their symptoms and improve their quality of life, including the following:

  • Bronchodilators
  • Inhaled corticosteroids
  • Cough medicine
  • Supplemental oxygen therapy
  • Lifestyle changes (such as changing occupations or quitting smoking)

The Lung Institute also offers an alternative approach to silicosis treatment through stem cell therapy. Unlike the above-listed treatment methods, which offer relief from symptoms but have no effect on the underlying condition itself, stem cell therapy has the potential to slow the progression of silicosis. Treatment involves a three-step process, consisting of collecting a blood or bone marrow sample from the patient, separating the stem cells from the rest of the sample and then returning the concentrated stem cells into the patient’s bloodstream. Once the stem cells are reintroduced into the patient’s body, they can promote natural healing and help to reduce inflammation within the lungs. Silicosis treatment using stem cell therapy is a minimally invasive process that can be completed on an outpatient basis over the course of two days.

If you would like to know more about how stem cell therapy can help with the treatment of silicosis, please contact the Lung Institute today at (800) 729-3065. We look forward to helping you breathe easier.


  1. Lung Institute

    6 days ago


    Inhalers can help with pain management and improve symptoms temporarily. They do not address the progression of the disease. The Lung Institute is able to treat people at any stage of COPD.

    You can learn more about stem cell treatments and have your questions answered by one of our qualified patient coordinators. Feel free to contact us at (855) 313-1149 for more information. We look forward to hearing from you soon.


    The Lung Institute

  2. Diane

    6 days ago

    Is Inhelers is not really good for copd PLEASE tell me what is good for copd HOW DO YOU DO ON THE LAST STAGE IF IT THE DR SAY I AM ON IT BUT I DONT THINK SO

  3. Lung Institute

    7 days ago


    Thank you for the message. We were not able to find any direct mention of silica gel (which is the silicone product used to dry and preserve flowers) causing silicosis. You may want to talk with your primary physician about it.

    Here is a link to a blog article we wrote regarding silicosis and its causes.

    We’re happy to answer your questions about stem cells, treatment options, candidacy and cost. So, feel free to contact us at (855) 313-1149. We look forward to hearing from you soon.


    The Lung Institute

  4. wanda johnston

    2 weeks ago

    Is this disease silicosis caused from inhaling silicone dust from the silicone products used to dry and preserve flowers ?

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.